Wednesday, September 12, 2012

Geron up AAPL up

Dead cat bounce for Geron? Maybe. With only GRN1005 and maybe a small, very small chance that the last two trial with imetelstat may work I can't put much hope in this company. So I sold 1000 shares at $1.30 for a $400 loss and sold 10 $1 covered calls for Mar 2013 for 55 cents, that would be a $1500 loss. I'm still going to keep 3-5 thousand shares till the GRN1005 trials are over and results are known. I can't believe a Geron could be 100% wrong on everything they have done. Even a blind squirrel finds a nut once in a while.
Geron was up 7 cents to close at $1.33 on 2.8 million shares. The three month avg. volume is 1.3 million shares.
Remember the last two imetelstat trial are going for the side effects of imetelstat that helps lower the red blood count, [I may have that a little wrong but it's the side effect of imetelstat, Geron is hoping that will work].

ACTC,  I thought was going to move up, but it closed down a little at 0.0845 on 9.4 million shares. The three month avg volume is 5 million shares. ACTC is the future in bio-tech.

AAPL iPhone 5 and it's up 9.20 to closed at $669.79 on 24.7 million shares. We go higher.

Good luck in this rigged casino,

Tuesday, September 11, 2012

Geron down and ACTC up over 9

Geron was down only two cent to close at $1.26 on 4.1 million shares. I sold 1000 shares at $1.26, will sell more and will sell some covered calls at $1.00. It's dark days ahead for Geron. I was surprised it didn't close lower. New 52 week low $1.23.

ACTC was up over 9 cents at 0.0914 on 15 million shares. I think we go higher.

Good luck in this rigged casino,

Monday, September 10, 2012

Geron down 55% closed at $1.28

The worst thing that could have happened,,,,,,,HAPPENED. The people being treated with the imetelstate were dying sooner then the people not taking imetelstate. It can't get worse than that. So Geron stopped the breast cancer trial and they stated the small cell lung cancer trial was not showing much improvement. So that means only two trials left using imetelstate, only a miracle will save these trials. Now that leave the two GRN1005 trials that will have results sometime in the 2Q of 2013. Maybe that will save Geron. My confidence in Geron is totally shot. I will be slowly selling my shares down to around 3,000 shares.
Geron closed down 55.86% at $1.28 on 19.5 million shares. The three month avg. volume is 976,773 shares.

Good luck in this rigged casino,

Disaster of the highest order for GERON

Geron Corp. (GERN, Trade ) shares fell 51%. The biotech firm said Monday that it's discontinuing its Phase II study of imetelstat in metastatic HER2-negative breast cancer because median progression-free survival was shorter than the comparison treatment.  I'm working tell I'm 70 or till I drop dead. Cry me a river.
DISASTER, DISASTER, DISASTER, DISASTER.

GOOD LUCK IN THIS RIGGED CASINO,

Saturday, September 8, 2012

ACTC Sept 10th webcast



ACTC chairman and CEO Gary Rabin will be presenting at the 14th Annual Rodman & Renshaw Global Investment Conference, Sept. 9-11 in New York. Mr. Rabin’s presentation will take place on Monday, Sept. 10, at 12:05 p.m. EDT, at the Waldorf Astoria. We need some good news.


Good luck in this rigged casino,

Friday, September 7, 2012

Geron new high again

Geron closed up 6 cents at $2.90 on 1.7 million shares. The new 52 week high is $2.99. The three month avg. volume is 967,411shares. What does the future hold for Geron? Here's my vision. Geron continues to $3.75-4.30. When Phase 2 oncology test results are announced in 4th quarter. With good news Geron spikes to $5.50-7.00. With good news in 1st quarter of 2013 on GRN1005. Geron spikes to $8-10. Shortly thereafter Geron is sold for $14-20.  Just a dream.

AAPL up again to close at $680.50 on 11.6 million shares. The three month avg. volume is 13.5 million shares.

ACTC closed up a little at 0.0828 on 3.1 million shares. The three month avg. volume is 4.7 million shares.

Good luck in this rigged casino,

Geron new high again

Geron was up to $2.98 so far today, which is a new 52 week high. Geron's around $2.95 now. The volume is not great, under 800,000 shares so far.  We're up from $1.71 on Aug 17th. to almost $3 today. Now think what will happen if the Phase two results are good. A guess would be a run to $6, maybe more and if Geron gets a partner, I can see $10. Down the road $20 with more good results. If the Phase two results are poor Geron trials under a $1. It's a big reward if I'm right. If I'm wrong I'll be crying me a river.

Good luck in this rigged casino,